Ryan Halsted
RBC Capital Markets, Research Division

Thanks for joining us. My name is Ryan Halsted. I am the health care technology and distribution analyst with RBC's healthcare research team, and we have Certara up next. And I am pleased to be joined by Jon Resnik, CEO; and John Gallagher, CFO. Certara is a tech-enabled drug development company. So welcome.

Jon Resnick
CEO & Director

Thank you, Ryan. Nice to be here. Thank you for the invite.

Ryan Halsted
RBC Capital Markets, Research Division

So John, I wanted to start with you. You've been in the CEO seat now for 5 months. And just wanted to get some perspectives from you on -- about the company since you joined, anything that surprised you or anything that's changed?

Jon Resnick
CEO & Director

It really only been 5 months. So I don't know if anything surprised me per se. I think there are some areas where maybe I underestimated just how strong of a franchise it was. I mean, specifically around kind of scientific leadership, the deep kind of regulatory expertise, methodological leadership, the closeness between the relationship, between the companies and the work that they do with regulators. I knew that was a core part of the value proposition, but it's really truly in the DNA.

Maybe the second area, and maybe this is a little bit of a surprise is around the portfolio itself. But there are a number of things that the company is known for, a number of kind of market-leading assets. But